Net Debt and Cash Flow
The Company ended the year with net debt of $303m. Cash on hand at 31 December 2017 was $56m and the Company had borrowings of $359m. The Company achieved positive net operating cash flow after interest, tax, working capital and oneoff items of $48.0m. Significant cash flow items during the period include $39.5m in capital expenditure, $23.2m payments for product development (expensed and capitalised), $17.8m in earn-out payments, $6.8m in net tax payments, $6.9m in net interest and a $8.8m working capital release
- Forums
- ASX - By Stock
- MYX new all time highs, if and when possible?
MYX
mayne pharma group limited
Add to My Watchlist
0.00%
!
$5.20

Net Debt and Cash Flow The Company ended the year with net debt...
-
-
- There are more pages in this discussion • 237 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.20 |
Change
0.000(0.00%) |
Mkt cap ! $422.4M |
Open | High | Low | Value | Volume |
$5.29 | $5.29 | $5.17 | $1.533M | 294.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | $5.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.29 | 4126 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 5.200 |
1 | 2500 | 5.190 |
1 | 10000 | 5.180 |
1 | 2500 | 5.160 |
1 | 1000 | 5.150 |
Price($) | Vol. | No. |
---|---|---|
5.290 | 4126 | 2 |
5.300 | 22900 | 2 |
5.320 | 3600 | 1 |
5.330 | 2000 | 1 |
5.350 | 25858 | 2 |
Last trade - 16.10pm 10/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |